AbCellera (Nasdaq: ABCL) today announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial Application (CTA) for ABCL575, an investigational antibody ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

Participating in clinical trials isn't just about personal survival—it's about creating a healthier future for loved ones.

This story contains details from testimony referencing suicide and suicidal ideations that are graphic, and some readers may ...

The FDA should now consider setting minimum thresholds for diverse inclusion, particularly in later-phase clinical trials. The FDA could also grant companies contingent approval (for example ...

Precision diagnostics in prostate cancer treatment (PREDICT): A phase 2 multi-arm biomarker-based study (Alliance A032102). This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

PR China bDrug Clinical Trial Center, Peking University Third Hospital, Beijing, PR China cDepartment of Clinical Research, State Key Laboratory of Oncology in South China, Guangdong Provincial ...

Results from the randomized phase 3 DREAMM-8 study of belantamab mafodotin plus ... Stratum A (post-neoadjuvant) 83.1 (77.1-87.8) 76.6 (69.6-82.1) 0.67 (0.44-1.03) 0.06 Clinical trial identification: ...

Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...

Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.